Integrated Investment Consultants, LLC Meridian Bioscience Inc Transaction History

Integrated Investment Consultants, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 19, 2022	SELL	$23.75 - $31.69 $712 - $950	-30 Reduced 0.26%	11,622 $354,000
Q1 2022 May 16, 2022	BUY	$19.97 - $26.94 $5,551 - $7,489	278 Added 2.44%	11,652 $302,000
Q4 2021 Jan 10, 2022	SELL	$17.46 - $21.61 $17 - $21	-1 Reduced 0.01%	11,374 $232,000
Q3 2021 Oct 28, 2021	BUY	$17.35 - $22.5 $2,307 - $2,992	133 Added 1.18%	11,375 $219,000
Q2 2021 Jul 21, 2021	BUY	$18.01 - $28.32 $202,468 - $318,373	11,242 New	11,242 $249,000

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Integrated Investment Consultants, LLC, based on Form 13F filings with the SEC.

Stay updated on Integrated Investment Consultants, LLC with notifications on news.